Radfar A, Unnikrishnan I, Lee H W, DePinho R A, Rosenberg N
The Immunology Program, Tufts University School of Medicine, Boston, MA 02111, USA.
Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13194-9. doi: 10.1073/pnas.95.22.13194.
The Ink4a/Arf locus encodes p16(Ink4a) and p19(Arf) and is among the most frequently mutated tumor suppressor loci in human cancer. In mice, many of these effects appear to be mediated by interactions between p19(Arf) and the p53 tumor-suppressor protein. Because Tp53 mutations are a common feature of the multistep pre-B cell transformation process mediated by Abelson murine leukemia virus (Ab-MLV), we examined the possibility that proteins encoded by the Ink4a/Arf locus also play a role in Abelson virus transformation. Analyses of primary transformants revealed that both p16(Ink4a) and p19(Arf) are expressed in many of the cells as they emerge from the apoptotic crisis that characterizes the transformation process. Analyses of primary transformants from Ink4a/Arf null mice revealed that these cells bypassed crisis. Because expression of p19(Arf) but not p16 (Ink4a) induced apoptosis in Ab-MLV-transformed pre-B cells, p19(Arf) appears to be responsible for these events. Consistent with the link between p19(Arf) and p53, Ink4a/Arf expression correlates with or precedes the emergence of cells expressing mutant p53. These data demonstrate that p19(Arf) is an important part of the cellular defense mounted against transforming signals from the Abl oncoprotein and provide direct evidence that the p19(Arf)-p53 regulatory loop plays an important role in lymphoma induction.
Ink4a/Arf基因座编码p16(Ink4a)和p19(Arf),是人类癌症中最常发生突变的肿瘤抑制基因座之一。在小鼠中,许多这些效应似乎是由p19(Arf)与p53肿瘤抑制蛋白之间的相互作用介导的。由于Tp53突变是由阿贝尔逊鼠白血病病毒(Ab-MLV)介导的多步骤前B细胞转化过程的一个共同特征,我们研究了Ink4a/Arf基因座编码的蛋白质是否也在阿贝尔逊病毒转化中发挥作用。对原代转化体的分析表明,在许多细胞从表征转化过程的凋亡危机中出现时,p16(Ink4a)和p19(Arf)均有表达。对来自Ink4a/Arf基因敲除小鼠的原代转化体的分析表明,这些细胞绕过了危机。由于p19(Arf)而非p16(Ink4a)的表达在Ab-MLV转化的前B细胞中诱导凋亡,p19(Arf)似乎是这些事件的原因。与p19(Arf)和p53之间的联系一致,Ink4a/Arf的表达与表达突变p53的细胞的出现相关或先于其出现。这些数据表明,p19(Arf)是针对来自Abl癌蛋白的转化信号所启动的细胞防御的重要组成部分,并提供了直接证据表明p19(Arf)-p53调节环在淋巴瘤诱导中起重要作用。